International Research in Chinese Medicine

Objective To explore the clinical effects of oral administration of traditional Chinese medicine and external treatment with traditional Chinese medicine prescriptions for patients with schistosomiasis. Methods This study included patients with schistosomiasis admitted to our hospital from April 2023 to April 2025, with a total of 86 cases enrolled. Two groups were divided according to the digital random table method. The control group (n=43) was treated with conventional Western medicine, while the observation group (n=43) was treated with internal administration of traditional Chinese medicine and external treatment with a self-designed traditional Chinese medicine prescription (Bi Gu Decoction) on this basis. The treatment conditions of the two groups were evaluated based on the improvement of symptoms, clinical treatment effects and adverse reactions. Results Compared with the symptom improvement indicators (the time for abdominal pain to subside, the time for fever to subside, and the time for mucus and bloody stool to subside), the observation group was significantly shorter than the control group, and there was a statistically significant difference between the groups (P < 0.05). By comparing the clinical efficacy assessment, the total effective rate of the observation group was significantly higher than that of the control group, and there was a statistically significant difference between the groups (P < 0.05). When comparing the adverse reactions, there was no statistically significant difference between the control group and the observation group (P > 0.05). Conclusion For patients with schistosomiasis, internal administration of traditional Chinese medicine and external treatment with traditional Chinese medicine prescriptions can further enhance the therapeutic effect, accelerate the resolution of symptoms, and have good safety.

Schistosomiasis; Traditional chinese medicine prescriptions; Adverse reactions